Human MDM1 activation kit by CRISPRa

CAT#: GA111243

MDM1 CRISPRa kit - CRISPR gene activation of human Mdm1 nuclear protein



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (2)
Rabbit Polyclonal Anti-MDM1 Antibody
    • 100 ul

CNY 5,250.00


MDM1 (Myc-DDK-tagged)-Human Mdm1 nuclear protein homolog (mouse) (MDM1), transcript variant 1
    • 10 ug

CNY 5,232.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol MDM1
Locus ID 56890
Kit Components

GA111243G1, MDM1 gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA111243G2, MDM1 gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA111243G3, MDM1 gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001205028, NM_001205029, NM_017440, NM_020128, NM_001354969, NM_001354970, NM_001354971, NM_001354972, NM_001354973, NM_001354974, NM_001368282
Synonyms FLJ95264
Summary This gene encodes a microtubule-binding nuclear protein that localizes to the centrioles of dividing cells and differentiating multiciliated cells and negatively regulates centriole duplication. The encoded protein is closely associated with the centriole barrel, and resides in the centriole lumen. Naturally-occurring mutations in the orthologous mouse gene are associated with age-related retinal degeneration. [provided by RefSeq, Feb 2019]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...